NCT03791476View on ClinicalTrials.gov

RUCONEST® as a Therapeutic Strategy to Reduce the Incidence of Delayed Graft Function

PHASE1UnknownINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

June 21, 2019

Primary Completion Date

January 31, 2022

Study Completion Date

January 31, 2022

Conditions
Kidney Failure
Interventions
DRUG

rhC1INH

C1 esterase inhibitor

OTHER

Saline Solution

saline solution

Trial Locations (1)

53792

RECRUITING

University of Wisconsin, Madison

Sponsors
All Listed Sponsors
collaborator

Pharming Technologies B.V.

INDUSTRY

lead

University of Wisconsin, Madison

OTHER